The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies

BackgroundThe effect of statins on the risk of dementia and Alzheimer’s disease (AD) is unclear.MethodsWe systematically searched EMBASE, Web of Science, PubMed, CENTRAL and ClinicalTrail.gov for cohort studies comparing incidence of new-onset dementia and AD between statin users and non-users. We a...

Full description

Saved in:
Bibliographic Details
Main Authors: Ye Du, Zhangjie Yu, Chengyi Li, Yanxing Zhang, Buyun Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1473796/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548304191225856
author Ye Du
Zhangjie Yu
Chengyi Li
Yanxing Zhang
Buyun Xu
Buyun Xu
author_facet Ye Du
Zhangjie Yu
Chengyi Li
Yanxing Zhang
Buyun Xu
Buyun Xu
author_sort Ye Du
collection DOAJ
description BackgroundThe effect of statins on the risk of dementia and Alzheimer’s disease (AD) is unclear.MethodsWe systematically searched EMBASE, Web of Science, PubMed, CENTRAL and ClinicalTrail.gov for cohort studies comparing incidence of new-onset dementia and AD between statin users and non-users. We applied the DerSimonian–Laird random effects method to pool hazard ratio (HR) with 95% confidence intervals (CI).ResultsWe included forty-two studies comprising 6,325,740 patients. Thirty-five cohort studies involving 6,306,043 participants were pooled and indicated that statin use was associated with a reduced risk of dementia (HR: 0.79, 95% CI: 0.71–0.88). Similarly, an analysis of 19 studies comprising 1,237,341 participants demonstrated a 29% decrease in the risk of AD among statin users (HR: 0.71, 95% CI: 0.60–0.85). In sensitivity analyses, diagnostic criteria for dementia/AD significantly affected the combined risk estimates. In subgroup analyses, compared to studies enrolling participants with a mean/median age over 70 years, those younger than 70 years exhibited greater efficacy of statins in preventing dementia (HR: 0.67, 95% CI: 0.56–0.81 vs HR: 0.86, 95% CI: 0.78–0.95; P = 0.02) and AD (HR: 0.47, 95% CI: 0.44–0.50 vs. HR: 0.81, 95% CI: 0.71–0.92; P < 0.01). Due to significant heterogeneity in the definitions of statin dosage and exposure duration, pooling the results was abandoned and most studies suggested that higher dosages and longer exposure duration of statins further reduce the risk of dementia and AD.ConclusionStatin use is associated with a reduced incidence of dementia and AD, which might be modified by ages.
format Article
id doaj-art-f7e9d1618c9e435792628f33c9bb5d46
institution Kabale University
issn 1663-9812
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-f7e9d1618c9e435792628f33c9bb5d462025-02-03T06:33:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-02-011610.3389/fphar.2025.14737961473796The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studiesYe Du0Zhangjie Yu1Chengyi Li2Yanxing Zhang3Buyun Xu4Buyun Xu5Department of Neurology, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, ChinaDepartment of Cardiology, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, ChinaSchool of Medicine, Shaoxing University, Shaoxing, ChinaDepartment of Neurology, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, ChinaDepartment of Cardiology, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, ChinaSchool of Medicine, Shaoxing University, Shaoxing, ChinaBackgroundThe effect of statins on the risk of dementia and Alzheimer’s disease (AD) is unclear.MethodsWe systematically searched EMBASE, Web of Science, PubMed, CENTRAL and ClinicalTrail.gov for cohort studies comparing incidence of new-onset dementia and AD between statin users and non-users. We applied the DerSimonian–Laird random effects method to pool hazard ratio (HR) with 95% confidence intervals (CI).ResultsWe included forty-two studies comprising 6,325,740 patients. Thirty-five cohort studies involving 6,306,043 participants were pooled and indicated that statin use was associated with a reduced risk of dementia (HR: 0.79, 95% CI: 0.71–0.88). Similarly, an analysis of 19 studies comprising 1,237,341 participants demonstrated a 29% decrease in the risk of AD among statin users (HR: 0.71, 95% CI: 0.60–0.85). In sensitivity analyses, diagnostic criteria for dementia/AD significantly affected the combined risk estimates. In subgroup analyses, compared to studies enrolling participants with a mean/median age over 70 years, those younger than 70 years exhibited greater efficacy of statins in preventing dementia (HR: 0.67, 95% CI: 0.56–0.81 vs HR: 0.86, 95% CI: 0.78–0.95; P = 0.02) and AD (HR: 0.47, 95% CI: 0.44–0.50 vs. HR: 0.81, 95% CI: 0.71–0.92; P < 0.01). Due to significant heterogeneity in the definitions of statin dosage and exposure duration, pooling the results was abandoned and most studies suggested that higher dosages and longer exposure duration of statins further reduce the risk of dementia and AD.ConclusionStatin use is associated with a reduced incidence of dementia and AD, which might be modified by ages.https://www.frontiersin.org/articles/10.3389/fphar.2025.1473796/fullAlzheimer’s diseasecohort studydementiastatinmeta-analysis
spellingShingle Ye Du
Zhangjie Yu
Chengyi Li
Yanxing Zhang
Buyun Xu
Buyun Xu
The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
Frontiers in Pharmacology
Alzheimer’s disease
cohort study
dementia
statin
meta-analysis
title The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
title_full The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
title_fullStr The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
title_full_unstemmed The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
title_short The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
title_sort role of statins in dementia or alzheimer s disease incidence a systematic review and meta analysis of cohort studies
topic Alzheimer’s disease
cohort study
dementia
statin
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1473796/full
work_keys_str_mv AT yedu theroleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT zhangjieyu theroleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT chengyili theroleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT yanxingzhang theroleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT buyunxu theroleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT buyunxu theroleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT yedu roleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT zhangjieyu roleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT chengyili roleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT yanxingzhang roleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT buyunxu roleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies
AT buyunxu roleofstatinsindementiaoralzheimersdiseaseincidenceasystematicreviewandmetaanalysisofcohortstudies